• temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • sneezing •itchy, watery eyes • runny nose • itching of the nose or throat • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies • reduces swelling of nasal passages • temporarily relieves sinus congestion and pressure • temporarily restores freer breathing through ...
• do not divide, crush, chew or dissolve the tablet adults and children 12 years and over 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor
Safety sealed: do not use if individual blister unit is open or torn store between 20° to 25°C (68° to 77°F) protect from light and store in a dry place
Loratadine, USP 10 mg
Pseudoephedrine sulfate, USP 240 mg
Antihistamine
Nasal decongestant
• temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
• sneezing •itchy, watery eyes
• runny nose • itching of the nose or throat
• temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies
• reduces swelling of nasal passages
• temporarily relieves sinus congestion and pressure
• temporarily restores freer breathing through the nose
• if you have ever had an allergic reaction to this product or any of its ingredients.
• if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product
• heart disease • thyroid disease
• high blood pressure • diabetes
• trouble urinating due to enlarged prostrate gland
• liver or kidney disease. Your doctor should determine if you need a different dose.
do not take more than directed. Taking more than directed may cause drowsiness.
• an allergic reaction to this product occurs. Seek medical help right away.
• symptoms do not improve within 7 days or are accompanied by a fever
• nervousness, dizziness or sleeplessness occurs
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
• do not divide, crush, chew or dissolve the tablet
adults and children 12 years and over | 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours |
children under 12 years of age | ask a doctor |
consumers with liver or kidney disease | ask a doctor |
black iron oxide, colloidal silicon dioxide, dibasic calcium phosphate anhydrous, ethyl cellulose, hypromellose, magnesium stearate, polyethylene glycol, povidone, propylene glycol, shellac
call toll free 1-888-235-2466 (Mon - Fri 9AM - 5PM EST)
KEEP OUTER CARTON FOR COMPLETE
WARNINGS AND PRODUCT INFORMATION
THIS PRODUCT IS PACKAGED IN A CHILD-RESITANT AND TAMPER EVIDENT PACKAGE.
Do not use if individual blister unit is open or torn.
†This product is not manufactured or distributed by the
owners of Claritin-D® 24 hour
MADE WITH PRIDE AND CARE FOR
H-E-B® , SAN ANTONIO, TX 78204
100%
GUARANTEE
promise
If you aren't completely pleased
with this product, we'll be happy to
replace it or refund your money.
You have our word on it.
PRODUCT OF INDIA
L0000918-R1024
KD/DRUGS/KTK/25/460/2001
Compare to CLARITIN-D® 24 HOUR active ingredients ƚ
NDC 37808-787-35
H.E.B
Allergy Relief-D
Loratadine and Pseudoephedrine Sulfate
Exrended-Release Tablets 10 mg/ 240 mg
Indoor & Outdoor Allergies
24
Hour
Non-Drowsy*
Antihistamine/Nasal Decongestant
Original Prescription Strength
15 days of Relief
Relief of:
• Nasal and Sinus Congestion Due to Colds or Allergies
• Sneexing • Runny Nose • Itchy, Watery Eyes
• Itchy Throat or Nose Due to Allergies
15 EXTENDED- RELEASE TABLETS
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1117562 | pseudoephedrine sulfate 240 MG / loratadine 10 MG 24HR Extended Release Oral Tablet | PSN | 1 |
| 1117562 | 24 HR loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet | SCD | 1 |
| 1117562 | loratadine 10 MG / pseudoephedrine sulfate 240 MG 24 HR Extended Release Oral Tablet | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| PSEUDOEPHEDRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| e974e22d-8688-7d92-1e87-40c1079e170c | Product name | 3 | 20151125 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 30c51294-7ae9-8007-7de6-58222684a0be | Product name | 1 | 20140508 |
| 4f26f669-fc6c-40ef-9e26-1c7b2390ee66 | Product name | 1 | 20140508 |
| 70a83adc-6047-bbea-5a08-dfd304aa47d2 | Product name | 1 | 20140508 |
| 858ce051-9941-aafc-8c7c-44a8e0227463 | Product name | 1 | 20140508 |
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 37808-787-07 | Allergy Relief-D | 5 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 5 | 1 | |
| 37808-787-07 | Allergy Relief-D | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 1 | |
| 37808-787-35 | Allergy Relief-D | 3 in 1 CARTON | TABLET, EXTENDED RELEASE | 3 | 1 | |
| 37808-787-35 | Allergy Relief-D | 5 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 5 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 37808-787 | 37808-787-07, 37808-787-35 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PSEUDOEPHEDRINE SULFATE | Y9DL7QPE6B | ACTIB |
| FERROSOFERRIC OXIDE | XM0M87F357 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | L11K75P92J | IACT |
| ETHYLCELLULOSES | 7Z8S9VYZ4B | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| POVIDONE | FZ989GH94E | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SHELLAC | 46N107B71O | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | LORATADINE; PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | 1e350fbaab3a… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218017-001 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | TABLET, EXTENDED RELEASE / ORAL | 2024-05-14 | a50c72e98297… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allergy Relief-D | LORATADINE AND PSEUDOEPHEDRINE SULFATE | HEB | 36230417-8687-d9fd-e063-6394a90ac2e5 | 2025-05-27 | Warnings | 37808-787-07 37808-787-35 37808-787 37808078707 37808078735 36230417-8688-d9fd-e063-6394a90ac2e5 36230417-8687-d9fd-e063-6394a90ac2e5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.